Literature DB >> 1819727

Presence of platelet-activating factor in pyuria in humans.

I Ikeda1, M Oda, M Sakakura, K Yasunaga.   

Abstract

The relationship between the occurrence of platelet-activating factor (PAF) and neutrophils in urine from patients with urinary tract infection was examined. PAF was detected in human pyuria, when leukocyte levels reached at least 300 cells/microL (n = 45), but not in normal urine (n = 12). The amount of PAF found in pyuria, measured by platelet aggregation assay, was 0.01 to 13.3 pmol/mL. A close correlation was seen between the amount of PAF present and the number of urinary leukocytes (p less than 0.01, r = 0.70). The leukocytes in pyuria consisted almost entirely of neutrophils (96 +/- 4%, mean +/- S.D.). Our findings suggest that the occurrence of PAF is associated with the accumulation of neutrophils in urine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819727     DOI: 10.1007/BF02536560

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  M Okamoto; K Yoshida; M Nishikawa; T Ando; M Iwami; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1986-02       Impact factor: 2.649

2.  Structural identification of platelet activating factor in psoriatic scale.

Authors:  A I Mallet; F M Cunningham
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

Review 3.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

4.  Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.

Authors:  M Oda; K Satouchi; K Yasunaga; K Saito
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

5.  Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

Authors:  R N Pinckard; R S Farr; D J Hanahan
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  The presence of platelet-activating factor associated with eosinophil and/or neutrophil accumulations in the pleural fluids.

Authors:  M Oda; K Satouchi; I Ikeda; M Sakakura; K Yasunaga; K Saito
Journal:  Am Rev Respir Dis       Date:  1990-06

7.  CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

Authors:  Z Terashita; Y Imura; M Takatani; S Tsushima; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

8.  Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus.

Authors:  R Nakayama; K Yasuda; K Saito
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

9.  Metabolism of 1-O-alkyl-2-acetyl-sn-glycerol by washed rabbit platelets: formation of platelet activating factor.

Authors:  K Satouchi; M Oda; K Saito; D J Hanahan
Journal:  Arch Biochem Biophys       Date:  1984-10       Impact factor: 4.013

10.  CV-3988 - a specific antagonist of platelet activating factor (PAF).

Authors:  Z Terashita; S Tsushima; Y Yoshioka; H Nomura; Y Inada; K Nishikawa
Journal:  Life Sci       Date:  1983-04-25       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.